Skip to content

Comparison of Optic Nerve Head and Retinal Nerve Fiber Layer Parameters Derived From Two Different Methods of Scan Alignment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02666144
Enrollment
48
Registered
2016-01-28
Start date
2016-02-29
Completion date
2016-03-31
Last updated
2016-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

This prospective, monocentric, non-invasive clinical study is designed to measure normal structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT device. This study is conducted in normal, healthy volunteers and glaucoma patients. The main goal of the study is to provide an analysis of the comparability of these parameters between two different software versions and their respective method of scan centration on the optic disc center. The study will include at least 40 eyes of 40 subjects; 20 normal, healthy subjects and 20 glaucoma patients. All subjects will undergo Spectralis OCT imaging, biometric and ophthalmoscopic examination, and visual field testing in one single visit. Total study duration (first patient first visit to last patient last visit) is anticipated to be approximately 4 weeks.

Interventions

Measurement of structural parameters of the optic nerve head (ONH), in particular, the neuroretinal rim of the ONH, and the peripapillary retinal nerve fiber layer.

Sponsors

Heidelberg Engineering GmbH
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Able and willing to undergo the test procedures, give consent, and to follow instructions * Subjects that understand the nature of the trial * Signed informed consent * Age : 18 years or older * For normal subjects, normal means, there is no reason that would prevent imaging of the eye, therefore: * Self-reported healthy eyes without prior intraocular surgery (except cataract surgery and laser in situ keratomileusis) and without clinically significant vitreal, retinal or choroidal diseases, diabetic retinopathy, or disease of the optic nerve (e.g. impacting central VA or RNFLT measurements as determined by the expertise of the investigator) * Visual field GHT within normal limits * For glaucoma subjects: Early to advanced glaucoma according to existing medical charts and visual field GHT outside normal limits on at least two occasions during the testing. * Refraction between +6 and -6 diopters spherical equivalent and astigmatism ≤ 2 diopters * When both eyes are eligible, one randomly selected eye will be evaluated in the analysis

Exclusion criteria

* Vulnerable subjects (as defined in ISO 14155 GCP)with the exception of employees of the site, and , if applicable, students of the respective university. Staff that is directly involved in the study is excluded from participation. * subjects unable to read or write * Unreliable visual field. The reliability indices should be used as guide as well as the perimetrist's notes. * Unusable disc stereo photos. * Inability to undergo the tests. * Insufficient quality of Spectralis OCT images (this is not determined until after Spectralis OCT examination, and is an unusual circumstance). Minimum requirements are: * Retina completely included in image frame, * Quality Score ≥ 20 in the stored ART mean images, and * For ONH-R scan: Center position error ≤ 100 μm. * Note: Inability of a subject to perform one of the two scan patterns or insufficient image quality in one scan pattern does not exclude the subject or eye from the study.

Design outcomes

Primary

MeasureTime frameDescription
Agreement (Differences) of peripapillary retinal nerve fiber layer thickness4 weeksAgreement (Differences) of peripapillary retinal nerve fiber layer thickness in sectors temporal, nasal, nasal superior, nasal inferior, temporal superior and temporal inferior when measured with two different software versions.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026